The Valley Desk

NCT00510068 · Interventional trial

Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors

Overall registry status Completed

Phase 3

Conditions Advanced Neuroendocrine Tumors of Pancreatic Origin

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov